Doug Liversidge has stepped down as non-executive director of Surgical Innovations Group. 
 
Liversidge had been in the role since 1998 and had served as chairman until October 2015 but has stepped down to focus on his other business activities.
 
Surgical Innovations Group executive chairman Nigel Rogers said: "Firstly, the board places on record our appreciation for the many years of leadership which Doug has provided to the company, and thanks him for his dedication and commitment”.
 
The company has also appointed two independent non-executive directors in Alistair Taylor and Paul Hardy.
 
Taylor has worked at Beecham Group and Pfizer and was previously chief executive officer of Biocompatibles and later chairman of Lombard Medical Technology. Hardy has owned and led Hardy Transaction Management, a boutique provider of merger and acquisition lead advisory services, since 2003.
 
Rogers said: "Looking to the future, we are delighted that Alistair and Paul are joining the board.  They bring both breadth and depth of experience and an excellent network of established contacts in our sector. They can offer extensive support in the continued improvement of our core activity, in business development and achieving operational excellence".